絞り込み

17069

広告

Sarcopenia as a significant predictive factor of neutropenia and overall survival in urothelial carcinoma patients underwent gemcitabine and cisplatin or carboplatin.

著者 Yumioka T , Honda M , Nishikawa R , Teraoka S , Kimura Y , Iwamoto H , Morizane S , Hikita K , Takenaka A
Int J Clin Oncol.2019 Sep 13 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (5view , 0users)

Full Text Sources

To evaluate the relationship between sarcopenia and myelosuppression or between sarcopenia and survival outcomes in patients with urothelial carcinoma (UC) undergoing chemotherapy with gemcitabine plus cisplatin (GC) or carboplatin (GCa).
PMID: 31520176 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード